Joseph E. Parrillo

Active 1978–2022

Also published as
JOSEPH E. PARRILLO
115
Papers
37,072
Citations
94
h-index
115
i10-index

Citations

Citations per year for Joseph E. Parrillo1971: 1 citations1978: 2 citations1979: 6 citations1980: 2 citations1981: 14 citations1982: 9 citations1983: 4 citations1984: 8 citations1985: 27 citations1986: 36 citations1987: 74 citations1988: 94 citations1989: 135 citations1990: 129 citations1991: 121 citations1992: 146 citations1993: 147 citations1994: 115 citations1995: 134 citations1996: 148 citations1997: 112 citations1998: 165 citations1999: 167 citations2000: 164 citations2001: 150 citations2002: 160 citations2003: 160 citations2004: 171 citations2005: 162 citations2006: 149 citations2007: 192 citations2008: 225 citations2009: 212 citations2010: 219 citations2011: 230 citations2012: 250 citations2013: 275 citations2014: 268 citations2015: 292 citations2016: 220 citations2017: 262 citations2018: 193 citations2019: 638 citations2020: 673 citations2021: 549 citations2022: 389 citations2023: 286 citations2024: 433 citations2025: 208 citations2026: 12 citations1972–1977: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,146 citing papers, 29.7% of this breakdownUnited Kingdom: 696 citing papers, 6.6% of this breakdownChina: 541 citing papers, 5.1% of this breakdownGermany: 541 citing papers, 5.1% of this breakdownFrance: 521 citing papers, 4.9% of this breakdownCanada: 516 citing papers, 4.9% of this breakdownItaly: 443 citing papers, 4.2% of this breakdownNetherlands: 385 citing papers, 3.6% of this breakdownAustralia: 355 citing papers, 3.4% of this breakdownJapan: 289 citing papers, 2.7% of this breakdownSpain: 251 citing papers, 2.4% of this breakdownBelgium: 244 citing papers, 2.3% of this breakdown
0%29.7%Other 25.1%

Fields

  • Medicine72.6%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Immunology and Microbiology8%
  • Engineering2.3%
  • Computer Science0.9%
  • Neuroscience0.9%
  • Other3.2%

Topics

  • Sepsis Diagnosis and Treatment13.1%
  • Immune Response and Inflammation3.8%
  • Hemodynamic Monitoring and Therapy3.3%
  • Bacterial Identification and Susceptibility Testing2.8%
  • Nosocomial Infections in ICU2.1%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation1.9%
  • Other73%

Coauthors

All papers

Open in search
  1. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*

    Authors: , , , , , , , , , , , , - Critical Care Medicine 2006 cited by 6,095

  2. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 cited by 370

  3. Profound but Reversible Myocardial Depression in Patients with Septic Shock

    Authors: , , , , , , , - Annals of Internal Medicine 1984 cited by 1,583

  4. Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock

    Authors: , , , , , , , , , , , , , , - CHEST Journal 2009 cited by 1,184

  5. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy

    Authors: , , , , , , , , , , , - Intensive Care Medicine 2008 cited by 501

  6. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models

    Authors: , , , , , , , , , , , , , - Circulation 2012 cited by 304

  7. Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19

    Authors: , , , , , , - Journal of the American College of Cardiology 2022 cited by 101

  8. Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width Biomarker

    Authors: , , , , , , , , , , , , , - CHEST Journal 2017 cited by 216

  9. Septic Shock in Humans

    Authors: , , , , , , - Annals of Internal Medicine 1990 cited by 1,194

  10. Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department Patients*

    Authors: , , , , , , , , , , , , , - Critical Care Medicine 2019 cited by 171

  11. A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 1989 cited by 351

  12. Multiple Organ Dysfunction After Return of Spontaneous Circulation in Postcardiac Arrest Syndrome

    Authors: , , , , , , - Critical Care Medicine 2013 cited by 162

  13. A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Critical Care Medicine 2013 cited by 322

  14. Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock

    Authors: , , , , , , , , - Critical Care Medicine 2014 cited by 150

  15. The Cardiovascular Response of Normal Humans to the Administration of Endotoxin

    Authors: , , , , , , - New England Journal of Medicine 1989 cited by 1,103

  16. Sepsis and Septic Shock: A History

    Authors: , , - Critical Care Clinics 2009 cited by 244

  17. Monocyte distribution width enhances early sepsis detection in the emergency department beyond SIRS and qSOFA

    Authors: , , , , , , , , , - Journal of Intensive Care 2020 cited by 95

  18. Pathogenetic Mechanisms of Septic Shock

    Authors: , - New England Journal of Medicine 1993 cited by 1,569

  19. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival

    Authors: , , , , , , , , , - Annals of Emergency Medicine 2006 cited by 601

  20. The coronary circulation in human septic shock.

    Authors: , , , , - Circulation 1986 cited by 475

  21. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

    Authors: , , , , , , , , , , , , , - Hepatology 2012 cited by 150

  22. Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

    Authors: , , , , , , , , , , , , , , , - Annals of Internal Medicine 1984 cited by 856

  23. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock

    Authors: , , , , - Critical Care Medicine 1987 cited by 506

  24. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*

    Authors: , , , , , , , , , , , , , , , , , , - Critical Care Medicine 2010 cited by 463